Funding statement. The four base studies and the reported analysis were sponsored by Eli Lilly and Company (Lilly USA, LLC; Indianapolis, IN, USA).
Efficacy and Safety of Once-Daily Tadalafil in Men with Erectile Dysfunction Who Reported No Successful Intercourse Attempts at Baseline
Article first published online: 4 OCT 2012
© 2012 International Society for Sexual Medicine
The Journal of Sexual Medicine
Volume 10, Issue 3, pages 844–856, March 2013
How to Cite
Shabsigh, R., Seftel, A. D., Kim, E. D., Ni, X. and Burns, P. R. (2013), Efficacy and Safety of Once-Daily Tadalafil in Men with Erectile Dysfunction Who Reported No Successful Intercourse Attempts at Baseline. Journal of Sexual Medicine, 10: 844–856. doi: 10.1111/j.1743-6109.2012.02898.x
Previous presentation. Selected findings were presented at the Sexual Medicine Society of North America 2011 Annual Fall Meeting, Las Vegas, NV, USA, November 10–13, 2011 (Moderated Poster 129).
ClinicalTrials.gov registration. Internal study identifiers H6D-MC-LVFZ (Clinicaltrials.gov identifier NCT00547183); H6D-MC-LVFP (NCT00381732); H6D-MC-LVGH (NCT00422734); and H6D-MC-LVCV (non–US trial; no NCT #).
- Issue published online: 4 MAR 2013
- Article first published online: 4 OCT 2012